QC

Qisheng Capital

Asia, Shanghai, China, Baoshan

Description

Qisheng Capital is an investment firm that offer investment management and consulting service.

Investor Profile

Qisheng Capital has made 2 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (50%)
  • Series B (50%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Qisheng Capital frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
CH
Asia, Beijing, China, Beijing
Co-Investments: 1
Frees Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
Fosun Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 1
Alibaba Health Information Technology
Asia, Beijing, China, Beijing
Co-Investments: 1
Huatai Zijin Investment
Asia, Jiangsu, China, Nanjing
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Westlake Venture Partners
North America, California, United States, Westlake Village
Co-Investments: 1

What are some of recent deals done by Qisheng Capital?

XellSmart

Minhang, Shanghai, China

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.

BiopharmaBiotechnologyPharmaceutical
Series BOct 21, 2024
Amount Raised: $14,046,917
Gloria spectrum

Hangzhou, Zhejiang, China

Gloria spectrum is a biotechnology company that offers spectrometry applications production and central laboratory services

BiopharmaBiotechnologyHealth CarePharmaceutical
Series UnknownMay 5, 2022